Reading this on a mobile device? Try our optimized mobile version here:

February 7, 2013
Sign upForwardArchive
News for the PBM Industry

  Featured Story 
  • Some Republican governors move on implementing ACA
    Some Republican governors have agreed to expand Medicaid eligibility or set up health insurance marketplaces in compliance with the Affordable Care Act, in spite of their party's history of opposition to the law. Despite the heated rhetoric surrounding the law, the governors have faced little criticism. Politico (Washington, D.C.) (2/5) LinkedInFacebookTwitterEmail this Story
  Legislative & Regulatory News 
  • Bipartisan House bill would end Medicare SGR
    Reps. Allyson Schwartz, D-Pa., and Joe Heck, R-Nev., introduced a bill to repeal Medicare's sustainable growth rate formula and identify new payment and delivery models based on specialty, practice type and region. The bill also increases payment updates for preventive care, primary care and coordinated care. MedPage Today (free registration) (2/6) LinkedInFacebookTwitterEmail this Story
  • Study finds subsidies will blunt impact of higher premiums
    Rules in the Affordable Care Act regarding rates insurers may charge older patients, mandatory benefits and cost caps will lead to higher premiums for some, especially young men, and lower premiums for women, older subscribers and others, a Kaiser Family Foundation study finds. Nonetheless, concerns about pending sticker shock have been exaggerated because ACA subsidies will offset most of the higher costs, one of the study's authors said. Kaiser Health News/Capsules blog (2/6) LinkedInFacebookTwitterEmail this Story
  Drug Industry Spotlight 
  • FDA finds more bogus Avastin in U.S. supply chain
    Counterfeit versions of bevacizumab, which is sold in the U.S. as Genentech's Avastin, has entered the U.S. drug supply chain, according to a warning from the FDA. The bogus drug is labeled as Roche Holding's Altuzan. That drug is not approved for sale in the U.S. Testing found one or more batches of the suspect drug lacked the active ingredient, and the fake products are linked to Medical Device King, Pharmalogical and Taranis Medical. HealthDay News (2/6), Yahoo/The Associated Press (2/6) LinkedInFacebookTwitterEmail this Story
  • Other News
I am never bored anywhere: being bored is an insult to oneself."
--Jules Renard,
French author


Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Contact PCMA
Charles Cote
Assistant Vice President, Strategic Communications
(202) 207-3610

Twitter  Follow PCMA on Twitter
About PCMA
PCMA is the national association representing America's pharmacy benefit managers (PBMs), which administer prescription drug plans for more than 210 million Americans with health coverage provided through Fortune 500 employers, health insurance plans, labor unions, and Medicare Part D. PCMA is dedicated to enhancing the proven tools and techniques pioneered by PBMs that generate savings and access for consumers and payors.

 Recent PCMA SmartBrief Issues:   Lead Editor:  Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information